| Literature DB >> 29382756 |
Qiumin Tan1,2, Lorenzo Brunetti3,4,5, Maxime W C Rousseaux6,2, Hsiang-Chih Lu6,7, Ying-Wooi Wan6,2, Jean-Pierre Revelli6, Zhandong Liu6,8, Margaret A Goodell2,3,4,8,9, Huda Y Zoghbi1,2,7,8,10.
Abstract
Capicua (CIC) regulates a transcriptional network downstream of the RAS/MAPK signaling cascade. In Drosophila, CIC is important for many developmental processes, including embryonic patterning and specification of wing veins. In humans, CIC has been implicated in neurological diseases, including spinocerebellar ataxia type 1 (SCA1) and a neurodevelopmental syndrome. Additionally, we and others have reported mutations in CIC in several cancers. However, whether CIC is a tumor suppressor remains to be formally tested. In this study, we found that deletion of Cic in adult mice causes T cell acute lymphoblastic leukemia/lymphoma (T-ALL). Using hematopoietic-specific deletion and bone marrow transplantation studies, we show that loss of Cic from hematopoietic cells is sufficient to drive T-ALL. Cic-null tumors show up-regulation of the KRAS pathway as well as activation of the NOTCH1 and MYC transcriptional programs. In sum, we demonstrate that loss of CIC causes T-ALL, establishing it as a tumor suppressor for lymphoid malignancies. Moreover, we show that mouse models lacking CIC in the hematopoietic system are robust models for studying the role of RAS signaling as well as NOTCH1 and MYC transcriptional programs in T-ALL.Entities:
Keywords: Capicua; MYC transcriptional program; NOTCH activation; T cell development; T-ALL
Mesh:
Substances:
Year: 2018 PMID: 29382756 PMCID: PMC5816173 DOI: 10.1073/pnas.1716452115
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205